Hyperphosphatemia: a serious limiting factor preventing the possible benefit from intravenous calcitriol therapy.
Arik
N
N
Başoglu
T
T
Sungur
C
C
Adam
B
B
Bedir
A
A
Kandemir
T
T
Coşkun
C
C
Bernay
I
I
D015502:Absorptiometry, Photon; D000469:Alkaline Phosphatase / Q000097:blood; D015519:Bone Density; D002117:Calcitriol / Q000008:administration & dosage / Q000627:therapeutic use*; D002118:Calcium / Q000097:blood; D006801:Humans; D006961:Hyperparathyroidism / Q000188:drug therapy* / Q000209:etiology*; D007275:Injections, Intravenous; D010710:Phosphates / Q000097:blood*; D006435:Renal Dialysis / Q000009:adverse effects; D014511:Uremia / Q000628:therapy*
D010710:Phosphates; D000469:Alkaline Phosphatase; D002117:Calcitriol; D002118:Calcium